184 related articles for article (PubMed ID: 36045266)
1. Outcomes of intracranial non-germinomatous germ cell tumors: a retrospective Asian multinational study on treatment strategies and prognostic factors.
Hong KT; Han JW; Fuji H; Byun HK; Koh KN; Wong RX; Lee HL; Yoon HI; Lee JH; Phi JH; Kim SK; Kim DS; Lyu CJ; Choi JY; Kang HJ; Chen YW; Lee YY; Im HJ; Ra YS; Do Ahn S; Low SYY; Looi WS; Park HJ; Suh YG; Suh CO; Wang KC; Tan EEK; Wong TT; Kim JY
J Neurooncol; 2022 Oct; 160(1):41-53. PubMed ID: 36045266
[TBL] [Abstract][Full Text] [Related]
2. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.
Satomi K; Takami H; Fukushima S; Yamashita S; Matsushita Y; Nakazato Y; Suzuki T; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Yoshimoto K; Tamura K; Maehara T; Sakai K; Sugiyama K; Yokogami K; Takeshima H; Nonaka M; Asai A; Ushijima T; Matsutani M; Nishikawa R; Ichimura K
Neuro Oncol; 2022 May; 24(5):834-846. PubMed ID: 34698864
[TBL] [Abstract][Full Text] [Related]
3. Intracranial Germ Cell Tumors in Adolescents and Young Adults: A 40-Year Multi-Institutional Review of Outcomes.
Lo AC; Hodgson D; Dang J; Tyldesley S; Bouffet E; Bartels U; Cheng S; Hukin J; Bedard PL; Goddard K; Laperriere N
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):269-278. PubMed ID: 31654785
[TBL] [Abstract][Full Text] [Related]
4. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy.
Murray MJ; Bailey S; Heinemann K; Mann J; Göbel UK; Saran F; Hale JP; Calaminus G; Nicholson JC
Int J Cancer; 2017 Aug; 141(3):621-635. PubMed ID: 28463397
[TBL] [Abstract][Full Text] [Related]
5. Relapsing intracranial germ cell tumours warrant retreatment.
Callec L; Lardy-Cleaud A; Guerrini-Rousseau L; Alapetite C; Vignon L; Chastagner P; Frappaz D; Faure-Conter C
Eur J Cancer; 2020 Sep; 136():186-194. PubMed ID: 32711377
[TBL] [Abstract][Full Text] [Related]
6. Logarithmic decrease of serum alpha-fetoprotein or human chorionic gonadotropin in response to chemotherapy can distinguish a subgroup with better prognosis among highly malignant intracranial non-germinomatous germ cell tumors.
Kawaguchi T; Kumabe T; Kanamori M; Saito R; Yamashita Y; Sonoda Y; Watanabe M; Tominaga T
J Neurooncol; 2011 Sep; 104(3):779-87. PubMed ID: 21359564
[TBL] [Abstract][Full Text] [Related]
7. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
Khatua S; Dhall G; O'Neil S; Jubran R; Villablanca JG; Marachelian A; Nastia A; Lavey R; Olch AJ; Gonzalez I; Gilles F; Nelson M; Panigrahy A; McComb G; Krieger M; Fan J; Sposto R; Finlay JL
Pediatr Blood Cancer; 2010 Jul; 55(1):42-6. PubMed ID: 20222020
[TBL] [Abstract][Full Text] [Related]
8. Bifocal intracranial tumors of nongerminomatous germ cell etiology: diagnostic and therapeutic implications.
Aizer AA; Sethi RV; Hedley-Whyte ET; Ebb D; Tarbell NJ; Yock TI; Macdonald SM
Neuro Oncol; 2013 Jul; 15(7):955-60. PubMed ID: 23640532
[TBL] [Abstract][Full Text] [Related]
9. Histologically confirmed pineal tumors and other germ cell tumors of the brain.
Schild SE; Scheithauer BW; Haddock MG; Wong WW; Lyons MK; Marks LB; Norman MG; Burger PC
Cancer; 1996 Dec; 78(12):2564-71. PubMed ID: 8952565
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 and PD-1 expression in pediatric central nervous system germ cell tumors.
Woods JK; Lidov HG; Ligon KL; Santagata S; Chi SN; Yeo KK; Alexandrescu S
Mod Pathol; 2022 Dec; 35(12):1770-1774. PubMed ID: 36057740
[TBL] [Abstract][Full Text] [Related]
11. Brain and Spinal Tumors Originating from the Germ Line Cells.
Wong TT; Tsai ML; Chang H; Hsieh KL; Ho DM; Lin SC; Yen HJ; Chen YW; Lee HL; Yang TF
Adv Exp Med Biol; 2023; 1405():421-455. PubMed ID: 37452948
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival in patients with primary intracranial germ cell tumors treated with surgery, platinum-based chemotherapy, and radiotherapy: a single-institution study.
Shimizu H; Motomura K; Ohka F; Aoki K; Tanahashi K; Hirano M; Chalise L; Nishikawa T; Yamaguchi J; Yoshida J; Natsume A; Wakabayashi T
J Neurosurg; 2020 Oct; ():1-9. PubMed ID: 33007755
[TBL] [Abstract][Full Text] [Related]
13. Intracranial germ cell tumors: a single-institution experience.
Khafaga Y; El Weshi A; Nazmy M; Hassounah M; Alshail E; Moussa E; Allam A; Alkofide A; Jamshed A; ELhusseiny G; Ezzat I; Jenkin D
Ann Saudi Med; 2012; 32(4):359-65. PubMed ID: 22705605
[TBL] [Abstract][Full Text] [Related]
14. Impact of tumor markers on diagnosis, treatment and prognosis in CNS germ cell tumors: correlations with clinical practice and histopathology.
Takami H; Graffeo CS; Perry A; Giannini C; Nakazato Y; Saito N; Matsutani M; Nishikawa R; Daniels DJ; Ichimura K
Brain Tumor Pathol; 2023 Apr; 40(2):124-132. PubMed ID: 36995447
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.
Takada A; Ii N; Hirayama M; Toyoda H; Matsubara T; Toyomasu Y; Kawamura T; Daimon T; Sakuma H; Nomoto Y
J Neurosurg Pediatr; 2018 Nov; 23(3):317-324. PubMed ID: 30497152
[TBL] [Abstract][Full Text] [Related]
16. A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors.
Kim JW; Kim WC; Cho JH; Kim DS; Shim KW; Lyu CJ; Won SC; Suh CO
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):625-31. PubMed ID: 22420971
[TBL] [Abstract][Full Text] [Related]
17. Roles of Tumor Markers in Central Nervous System Germ Cell Tumors Revisited with Histopathology-Proven Cases in a Large International Cohort.
Takami H; Graffeo CS; Perry A; Giannini C; Nakazato Y; Saito N; Matsutani M; Nishikawa R; Ichimura K; Daniels DJ
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205726
[TBL] [Abstract][Full Text] [Related]
18. Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
Calaminus G; Frappaz D; Kortmann RD; Krefeld B; Saran F; Pietsch T; Vasiljevic A; Garre ML; Ricardi U; Mann JR; Göbel U; Alapetite C; Murray MJ; Nicholson JC
Neuro Oncol; 2017 Nov; 19(12):1661-1672. PubMed ID: 29048505
[TBL] [Abstract][Full Text] [Related]
19. MRI features of pediatric intracranial germ cell tumor subtypes.
Wu CC; Guo WY; Chang FC; Luo CB; Lee HJ; Chen YW; Lee YY; Wong TT
J Neurooncol; 2017 Aug; 134(1):221-230. PubMed ID: 28551848
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcome and long-term follow-up of central nervous system germ cell tumor using upfront chemotherapy with subsequent photon or proton radiation therapy: a single tertiary center experience of 127 patients.
Hong KT; Lee DH; Kim BK; An HY; Choi JY; Phi JH; Cheon JE; Kang HJ; Kim SK; Kim JY; Park SH; Kim IH; Shin HY
BMC Cancer; 2020 Oct; 20(1):979. PubMed ID: 33036578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
